Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis

被引:110
作者
Herszenyi, Laszlo [1 ]
Hritz, Istvan [1 ]
Pregun, Istvan [1 ]
Sipos, Ferenc [1 ]
Juhasz, Mark [1 ]
Molnar, Bela [1 ]
Tulassay, Zsolt [1 ]
机构
[1] Semmelweis Univ, Dept Med 2, Hungarian Acad Sci, Clin Gastroenterol Res Unit, H-1088 Budapest, Hungary
关键词
glutathione S-transferase; matrix metalloproteinase-9; Barrett's metaplasia; esophagus; adenocarcinoma; dysplasia;
D O I
10.3748/wjg.v13.i5.676
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the role of glutathione S-transferase (GST) and matrix meta lloproteinase-9 (MMP-9) expressions in the development and progression of reflux esophagitis-Barrett's meta plasia-dysplasia-adenocarcinoma sequence in the esophagus. METHODS: GST and MMP-9 expressions were analyzed in 51 paraffin-embedded tissue samples by immunohistochemistry including patients with reflux esophagitis (n = 7), Barrett's metaplasia (n = 14), Barrett and esophagitis (n = 8), Barrett and dysplasia (n = 7), esophageal adenocarcinoma (n = 8) and a control group without any histological changes (n = 7). Immunostaining was determined semiquantitatively. Statistical analysis with one-way ANOVA, LSD test and correlation analysis were performed. P value of < 0.05 was considered significant. RESULTS: GST expression was significantly higher while MMP-9 expression was significantly lower in control group compared to Barrett's metaplasia and the other groups. No major changes were observed between Barrett, esophagitis, and Barrett and concomitant esophagitis. Barrett and concomitant dysplasia, and adenocardnoma revealed a significant lower expression of GST and higher levels of MMP-9 compared to all other groups. Adenocarcinoma showed almost no expression of GST and significantly higher levels of MMP-9 than Barrett and concomitant dysplasia. Alterations of GST and MMP-9 were inversely correlated (r 0.82). CONCLUSION: Decreased GST and increased expression of MMP-9 in Barrett's meta plasia-clysplasiaadenocarcinoma sequence as compared to normal tissue suggest their association with esophageal tumorigenesis. Loss of GST and gain of MMP-9 in Barrett with dysplasia compared to non-clysplastic metaplasia indicate that these alterations may be early events in carcinogenesis. Quantification of these parameters in Barrett's esophagus might be useful to identify patients at higher risk for progression to cancer. (c) 2007 The WJG Press. All rights reserved.
引用
收藏
页码:676 / 682
页数:7
相关论文
共 44 条
[1]
Incipient angiogenesis in Barrett's epithelium and lymphangiogenesis in Barrett's adenocarcinoma [J].
Auvinen, MI ;
Sihvo, EIT ;
Ruohtula, T ;
Salminen, JT ;
Koivistoinen, A ;
Siivola, P ;
Rönnholm, R ;
Rämö, JO ;
Bergman, M ;
Salo, JA .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (13) :2971-2979
[2]
Glutathione S-transferase-Pi expression is downregulated in patients with Barrett's esophagus and esophageal adenocarcinoma [J].
Brabender, J ;
Lord, RV ;
Wickramasinghe, K ;
Metzer, R ;
Schneider, PM ;
Park, JM ;
Hölscher, AH ;
DeMeester, TR ;
Danenberg, KD ;
Danenberg, PV .
JOURNAL OF GASTROINTESTINAL SURGERY, 2002, 6 (03) :359-367
[3]
Alteration of glutathione S-transferase levels in Barrett's metaplasia compared to normal oesophageal epithelium [J].
Cobble, SC ;
Scobie, GC ;
Pohler, E ;
Hayes, JD ;
Kernohan, NM ;
Dillon, JF .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2003, 15 (01) :41-47
[4]
THE ROLE OF GLUTATHIONE AND GLUTATHIONE TRANSFERASES IN CHEMICAL CARCINOGENESIS [J].
COLES, B ;
KETTERER, B .
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 25 (01) :47-70
[5]
Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers [J].
Curran, S ;
Dundas, SR ;
Buxton, J ;
Leeman, MF ;
Ramsay, R ;
Murray, GI .
CLINICAL CANCER RESEARCH, 2004, 10 (24) :8229-8234
[6]
Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness [J].
Etoh, T ;
Inoue, H ;
Yoshikawa, Y ;
Barnard, GF ;
Kitano, S ;
Mori, M .
GUT, 2000, 47 (01) :50-56
[7]
Increased levels of cathepsin B and L, urokinase-type plasminogen activator and its inhibitor type-1 as an early event in gastric carcinogenesis [J].
Farinati, F ;
Herszenyi, L ;
Plebani, M ;
Carraro, P ;
DePaoli, M ;
Cardin, R ;
Roveroni, G ;
Rugge, M ;
Nitti, D ;
Grigioni, WF ;
DErrico, A ;
Naccarato, R .
CARCINOGENESIS, 1996, 17 (12) :2581-2587
[8]
Guzinska-Ustymowicz K, 2006, ANTICANCER RES, V26, P1589
[9]
Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma [J].
Heath, EI ;
Burtness, BA ;
Kleinberg, L ;
Salem, RR ;
Yang, SC ;
Heitmiller, RF ;
Canto, MI ;
Knisely, JPS ;
Topazian, M ;
Montgomery, E ;
Tsottles, N ;
Pithavala, Y ;
Rohmiller, B ;
Collier, M ;
Forastiere, AA .
INVESTIGATIONAL NEW DRUGS, 2006, 24 (02) :135-140
[10]
Herszènyi L, 1999, CANCER, V86, P1135, DOI 10.1002/(SICI)1097-0142(19991001)86:7<1135::AID-CNCR6>3.0.CO